Phoenix Insurance Company Limited (DSE:PHENIXINS)

Intra-Cellular Therapies Income Statement

Financials in millions BDT. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Premiums & Annuity Revenue	413.32	418.63	274.1	378.48	380.32	337.87
Total Interest & Dividend Income	23.13	36.56	31.07	32.49	33.55	45.75
Gain (Loss) on Sale of Investments	0.4	0.4	-2.03	-	-	0.79
Other Revenue	62.71	67.89	80.21	53.06	69.93	85.72
Total Revenue	499.56	523.47	383.35	464.02	483.8	470.14
Revenue Growth (YoY)	27.55%	36.55%	-17.39%	-4.09%	2.91%	-19.28%
Policy Benefits	52.23	77.39	-77.1	7.55	60.72	4.95
Policy Acquisition & Underwriting Costs	99.69	99.69	90.98	80.14	46.25	85.23
Depreciation & Amortization	37.36	37.36	36.42	34.15	11.94	10.79
Selling, General & Administrative	232.99	232.99	238.48	227.58	239.65	236.87
Total Operating Expenses	428.2	453.36	299.93	359.42	369.56	346.83
Operating Income	71.36	70.11	83.42	104.6	114.25	123.31
Other Non Operating Income (Expenses)	-1.51	-1.51	-1.21	-1.52	-1.03	-1.69
EBT Excluding Unusual Items	69.85	68.6	82.21	103.08	113.22	121.62
Gain (Loss) on Sale of Assets	0.89	0.89	-0.35	1.86	3.71	0.27
Pretax Income	70.74	69.5	81.86	104.95	116.93	121.89
Income Tax Expense	7.9	8.61	17.67	23.45	28.14	27.9
Net Income	62.84	60.88	64.19	81.49	88.79	93.99
Net Income to Common	62.84	60.88	64.19	81.49	88.79	93.99
Net Income Growth	27.47%	-5.15%	-21.23%	-8.22%	-5.53%	1.06%
Shares Outstanding (Basic)	40	40	40	40	40	40
Shares Outstanding (Diluted)	40	40	40	40	40	40
EPS (Basic)	1.56	1.51	1.59	2.02	2.20	2.33
EPS (Diluted)	1.56	1.51	1.59	2.02	2.20	2.33
EPS Growth	27.91%	-5.15%	-21.23%	-8.22%	-5.53%	1.06%
Free Cash Flow	-40.02	-11.35	27.26	39.49	148.57	73.32
Free Cash Flow Per Share	-0.99	-0.28	0.68	0.98	3.68	1.82
Dividend Per Share	1.000	1.000	1.200	1.500	1.500	1.500
Dividend Growth	-16.67%	-16.67%	-20.00%	-	-	25.00%
Operating Margin	14.29%	13.39%	21.76%	22.54%	23.61%	26.23%
Profit Margin	12.58%	11.63%	16.74%	17.56%	18.35%	19.99%
Free Cash Flow Margin	-8.01%	-2.17%	7.11%	8.51%	30.71%	15.60%
EBITDA	83.53	82.5	94.95	118.18	126.18	134.09
EBITDA Margin	16.72%	15.76%	24.77%	25.47%	26.08%	28.52%
D&A For EBITDA	12.17	12.39	11.53	13.57	11.94	10.79
EBIT	71.36	70.11	83.42	104.6	114.25	123.31
EBIT Margin	14.29%	13.39%	21.76%	22.54%	23.61%	26.23%
Effective Tax Rate	11.16%	12.39%	21.58%	22.35%	24.07%	22.89%

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.